China SXT Pharmaceuticals, Inc. (SXTC) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: $293.0K2018: $1.92M2019: $239.2K2020: $934.2K2021: -$1.32M2022: $268.3K2023: -$80.8K2024: -$1.93M2025: -$2.35M-$2.35M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$2.35M-21.6%
2024-$1.93M-2287.5%
2023-$80.8K-130.1%
2022$268.3K+120.4%
2021-$1.32M-240.9%
2020$934.2K+290.6%
2019$239.2K-87.5%
2018$1.92M+555.3%
2017$293.0K